Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil 56189-85991, Iran.
Energy Management Research Center, University of Mohaghegh Ardabili, Ardabil 56199-11367, Iran.
Medicina (Kaunas). 2023 Jan 26;59(2):227. doi: 10.3390/medicina59020227.
The Mediterranean diet's bioactive components are suggested to strengthen the immune system and to exert anti-inflammatory actions. This study investigated the association between adherence to the Mediterranean diet with serum inflammatory factors, total antioxidant capacity, appetite, and symptoms of COVID-19 patients. This cross-sectional study was conducted among 600 Iranian COVID-19 patients selected by a simple random method. The ten-item Mediterranean diet adherence questionnaire was used to assess diet adherence. At the beginning of the study, 5 cc of blood was taken from all patients for measurement of serum interleukin 1β) IL-1β), tumor necrosis factor (TNF-α), malondialdehyde (MDA), high sensitivity C-reactive protein (hs-CRP) and total antioxidant capacity (TAC). A human ELISA kit with serial number 950.090.096 produced by the Diaclone Company was used to test this cytokine using the sandwich ELISA method. One hundred and five patients presented a high adherence and 495 patients presented a low adherence to the Mediterranean diet. The incidence of fever, cough, diarrhea, taste changes, and pneumonia severity index were significantly lower in patients who adhered to the Mediterranean diet more than other patients. Serum levels of tumor necrosis factor (5.7 ± 2.1 vs. 6.9 ± 2.8 = 0.02), interleukin 1 beta (3.2 ± 0.02 vs. 4.9 ± 0.01 = 0.02), high-sensitivity C-reactive protein (17.08 ± 4.2 vs. 19.8 ± 2.5 = 0.03), and malondialdehyde (5.7 ± 0.2 vs. 6.2 ± 0.3 = 0.02) were significantly lower in patients who adhered more to the Mediterranean diet than other patients. The Mediterranean diet can improve the symptoms and elevated serum inflammatory factors in COVID-19 patients, so clinical trial studies are suggested to confirm this effect.
地中海饮食的生物活性成分被认为可以增强免疫系统并发挥抗炎作用。本研究调查了地中海饮食与血清炎症因子、总抗氧化能力、食欲和 COVID-19 患者症状之间的关系。这项横断面研究在 600 名伊朗 COVID-19 患者中进行,采用简单随机方法选择。使用十项地中海饮食依从性问卷评估饮食依从性。在研究开始时,从所有患者中抽取 5 cc 血液用于测量血清白细胞介素 1β(IL-1β)、肿瘤坏死因子(TNF-α)、丙二醛(MDA)、高敏 C 反应蛋白(hs-CRP)和总抗氧化能力(TAC)。使用 Diaclone 公司生产的编号为 950.090.096 的人 ELISA 试剂盒,采用夹心 ELISA 法检测这种细胞因子。105 名患者表现出高依从性,495 名患者表现出低依从性。与其他患者相比,更遵循地中海饮食的患者发热、咳嗽、腹泻、味觉改变和肺炎严重指数的发生率显著降低。血清肿瘤坏死因子(5.7 ± 2.1 与 6.9 ± 2.8, = 0.02)、白细胞介素 1β(3.2 ± 0.02 与 4.9 ± 0.01, = 0.02)、高敏 C 反应蛋白(17.08 ± 4.2 与 19.8 ± 2.5, = 0.03)和丙二醛(5.7 ± 0.2 与 6.2 ± 0.3, = 0.02)水平明显低于其他患者。地中海饮食可以改善 COVID-19 患者的症状和升高的血清炎症因子,因此建议进行临床试验研究以确认这种效果。